Quanome Technologies, Inc. financials

QNME CIK 0001996192

Source: EDGAR filings · Built 2026-10-03T00:02:37Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2024
Free Cash Flow -3.19M -2.71M — 375
EBITDA -10.05M -1.42M -454.06K 377.65K
Working Capital 6.53M 612.87K -2.35M -338.55K
Net Debt -425.96K 542.01K 8.15M 2.23M
Gross Margin 56.66% 56.11% 20.29% 19.92%
Operating Margin -174.21% -53.95% -2.87% 1.92%
Net Margin -162.10% -189.91% -1.23% 7.64%
Return on Equity (ROE) -135.37% -184.35% -35.21% 114.13%
Return on Assets (ROA) -81.38% -36.42% -2.45% 17.98%
Current Ratio 2.46× 1.06× 0.60× 0.88×
Debt-to-Equity 0.03× 1.88× 12.93× 2.78×
Effective Tax Rate -0.91% -12.59% 22.78% 6.45%
Cash Conversion Ratio 0.34× 0.51× 0.24× 0.04×
Accruals Ratio -0.54× -0.18× -0.02× 0.17×
CapEx Coverage -1554.54× -51.84× — 1.01×
Free Cash Flow Per Share $-0.12 $-0.36 — $0.00

Income Statement

Concept FY 2026FY 2025FY 2024FY 2024
Revenues 5.85M 2.76M 18.32M 12.87M
Cost of Revenue 2.54M 1.21M 14.60M 10.31M
Gross Profit 3.32M 1.55M 3.72M 2.56M
Operating Expenses 13.51M 3.04M 4.24M 2.32M
Operating Income (Loss) -10.19M -1.49M -526.04K 246.90K
Income Tax Expense (Benefit) 91.71K 212.30K -67.34K 65.07K
Net Income (Loss) Attributable to Parent -9.48M -5.25M -225.25K 983.60K
Earnings Per Share, Basic $-0.36 $-0.69 $-0.04 $0.16
Weighted Average Number of Shares Outstanding, Basic 25.72M 7.56M 6.00M 6.00M
Earnings Per Share, Diluted $-0.36 $-0.69 $-0.04 $0.16
Weighted Average Number of Shares Outstanding, Diluted 25.72M 7.56M 6.00M 6.00M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 670.28K 4.81M 123.55K 174.02K
Assets, Current 11.02M 10.28M 3.54M 2.44M
Assets 11.65M 14.41M 9.19M 5.47M
Long-term Debt — 1.36M 883.34K —
Liabilities, Current 4.49M 9.67M 5.89M 2.77M
Liabilities 4.65M 11.56M 8.55M 4.62M
Stockholders' Equity Attributable to Parent 7.01M 2.85M 639.79K 861.83K
Common Stock, Shares, Outstanding 34.43M 10.50M 6.00M 6.00M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2024
Net Cash Provided by (Used in) Operating Activities — -2.66M -53.64K 39.30K
Payments to Acquire Property, Plant, and Equipment 2.05K 20.44K — 18.29K
Net Cash Provided by (Used in) Investing Activities — -688.26K -78.80K -18.29K
Payments for Repurchase of Common Stock — 805.95K — 47.54K
Net Cash Provided by (Used in) Financing Activities — 8.17M 78.75K -253.09K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (QNME CIK 0001996192), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MDXH

MDXHEALTH SA

TRVI

Trevi Therapeutics, Inc.

CSDX

CS DIAGNOSTICS CORP.